MGH Expands Its Nurse Practitioner Training in Reproductive Psychiatry for 2027
The MGH Center for Women’s Mental Health is opening another round of its NP Masterclass in 2027, positioning the program as a focused educational pathway for nurse practitioners working in reproductive mental health. The course is built around direct faculty access, live case consultation, and didactic teaching from MGH and Harvard clinicians, with Lee Cohen, Marlene Freeman, and colleagues leading the curriculum. Enrollment will be limited to a small cohort, and the program carries a one-time fee of $2,000 for those accepted.
This is not a broad survey course for general mental health training. It is structured as a concentrated professional track for clinicians who already practice in settings where pregnancy, postpartum transitions, hormonal change, and psychiatric illness overlap in clinically consequential ways.
The design reflects a simple bedside reality: reproductive psychiatry rarely presents as an abstract diagnosis. It appears in urgent decisions about antidepressant exposure in pregnancy, the management of bipolar disorder across gestation and the postpartum period, and the interpretation of symptoms that can be misread as ordinary distress when they may signal a serious psychiatric syndrome.
A Small Cohort Built Around Case-Based Learning
The 2027 program will include 12 live sessions running from January through June, with meetings scheduled every other Monday from 1 to 2 PM EST unless otherwise specified. The course begins January 11, 2027, and the listed session dates extend through June 28. That structure favors repetition and continuity rather than a one-off lecture series, which matters when the material requires ongoing synthesis across diagnoses, medication decisions, and patient-specific risk assessment.
Only 50 participants will be admitted, preserving a format in which live discussion can stay intimate and clinically specific. In a field where one patient’s history of postpartum psychosis, another’s depression during pregnancy, and a third’s substance use disorder can demand very different management strategies, a smaller cohort allows faculty to address nuance in real time. The program also includes a members-only community and dedicated list-serve, creating a professional network that can outlast the course itself.
One sentence captures the educational intent clearly: the program is built for live clinical reasoning, not passive observation.
Curriculum Centers on High-Stakes Perinatal and Reproductive Questions
The syllabus spans the psychiatric conditions most likely to challenge clinicians across the reproductive life span. Topics include major depressive disorder during pregnancy, postpartum psychosis with insight from the MGH Postpartum Psychosis Project, specialized psychotherapies across the perinatal period, pharmacologic intervention for substance use disorders in pregnancy and postpartum, and bipolar disorder across pregnancy and the postpartum period. It also extends beyond the perinatal window to cover ADHD in women across the reproductive life span, menopause-related mental health symptoms, and practical guidance on what clinicians “always” and “never” do in reproductive psychiatry.
That range is clinically sensible. Perinatal psychiatry does not begin and end with delivery; it often overlaps with infertility treatment, miscarriage, postpartum recovery, lactation questions, and later-life hormone transitions. Medication selection in these settings is shaped by fetal and neonatal safety, maternal relapse prevention, prior treatment response, and the danger of undertreating disorders that can destabilize family functioning and maternal health. The inclusion of lessons from the National Pregnancy Registry for Psychiatric Medications also signals a strong evidence-based orientation, since registry data remain central to counseling patients who need medication but fear exposure.
The syllabus suggests an educational model that treats psychiatry as longitudinal care rather than a series of isolated episodes. In reproductive medicine, that is often the difference between reflexive prescribing and deliberate risk-benefit analysis.
Application Dates, Faculty Access, and Professional Recognition
The application process for 2027 is selective, with final decisions made by Cohen and Freeman. Applications open September 22, 2026, and rolling admissions begin October 15, 2026, with decisions communicated by email. The program begins January 11, 2027.
Alongside the teaching itself, the Masterclass offers professional recognition in the form of an “NP Masterclass” e-certificate upon graduation. Participants also receive a 20% discount on MGH Center for Women’s Mental Health-affiliated CME courses and conferences in 2027, though CME credits are not available for the Masterclass at this time. The structure is designed to reward commitment with both credentialed recognition and ongoing access to future educational offerings.
Interest in the program has also prompted the center to signal a possible educational pathway for physician assistants, with a tentative launch planned for mid-2027. For now, however, the 2027 cohort remains specific to nurse practitioners, reinforcing the program’s original purpose as a tailored curriculum for that professional group.
Why Reproductive Psychiatry Training Matters at the Point of Care
The clinical value of this program lies in its emphasis on problems that carry immediate consequences if they are misunderstood. Postpartum psychosis can become a psychiatric emergency. Untreated bipolar disorder in pregnancy can threaten maternal stability and complicate postpartum care. Depression during pregnancy affects not only the patient’s well-being but also the quality of obstetric and psychiatric decision-making that follows. Substance use disorders add another layer of complexity, particularly when medication-based treatment must be matched with the realities of perinatal care.
Training that is tightly linked to those realities can improve more than knowledge recall. It can sharpen triage, strengthen medication counseling, and reduce the likelihood that severe symptoms will be minimized because they occur during a period often framed as emotionally expected or physiologically inevitable. In that respect, a masterclass in reproductive psychiatry serves a practical function: it prepares clinicians to recognize when ordinary stress has crossed into illness, and when treatment decisions must be made quickly, carefully, and with the patient’s reproductive context fully in view.
The program’s most concrete limitation is also visible in its design. Enrollment is capped, and CME credit is not offered, so access will remain limited to a small number of applicants who can commit time and resources to an intensive educational track. Even so, the content focus, faculty leadership, and case-based format give the 2027 cohort a narrow but clearly defined mission: deepen the clinical management of reproductive psychiatric illness where the stakes are highest.